AORT insider files Form 144 to sell 10,802 shares on NYSE valued $471.8K

Rhea-AI Filing Summary

Artivion, Inc. (AORT) filed a Form 144 reporting a proposed sale of common stock. The filing shows 10,802 shares intended for sale on 08/12/2025 through Morgan Stanley Smith Barney LLC on the NYSE with an aggregate market value of $471,752.51. The issuer's outstanding shares are listed as 47,183,658.

The securities were acquired on 08/12/2025 through a stock option exercise from the issuer and paid in cash. The filer reports "Nothing to Report" for securities sold during the past three months. The notice includes the standard representation that the seller does not possess undisclosed material adverse information about the issuer.

Insights

Financial Analyst

TL;DR: A routine Form 144 for 10,802 shares valued at $471,752; size and disclosure suggest limited investor impact.

The filing documents a proposed sale of 10,802 common shares on 08/12/2025 via Morgan Stanley Smith Barney LLC on the NYSE, with an aggregate market value of $471,752.51 and 47,183,658 shares outstanding. The shares were acquired the same day by stock option exercise and paid in cash. No prior sales are reported for the past three months. From a trading-impact perspective, the transaction is modest relative to typical market volumes and the filing meets Rule 144 disclosure conventions.

Corporate Governance Expert

TL;DR: Documentation aligns with Rule 144 mechanics; includes seller's certification on material nonpublic information.

The Form 144 lists the broker, class of security, acquisition method (stock option exercise), payment type (cash), and that there were no sales in the preceding three months. The filing also contains the signature representation that the seller does not possess undisclosed material adverse information. These elements indicate procedural compliance with Rule 144 disclosure requirements; there is no evidence in the filing of aggregated sales or additional beneficiaries requiring disclosure.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	10802	471752.51	47183658	08/12/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	08/12/2025	Stock Option Exercise	Issuer			10802	08/12/2025	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

How many Artivion (AORT) shares are reported for proposed sale in this Form 144?

The filing reports 10,802 common shares proposed for sale.

What is the aggregate market value of the shares in the AORT Form 144?

The aggregate market value is reported as $471,752.51.

When were the AORT shares acquired and by what method?

The shares were acquired on 08/12/2025 via a stock option exercise from the issuer.

Through which broker and exchange will the AORT shares be sold?

The broker is Morgan Stanley Smith Barney LLC and the sale is listed for the NYSE.

Does the filing report any securities sold in the past three months for the seller?

The filing states "Nothing to Report" for securities sold during the past three months.

How were the shares paid for according to the filing?

Payment for the acquired shares is listed as cash.